Selltm2Alb
Targeted Allele Detail
|
Symbol: |
Selltm2Alb |
Name: |
selectin, lymphocyte; targeted mutation 2, Arthur L Beaudet |
MGI ID: |
MGI:3767069 |
Synonyms: |
E/P/I |
Gene: |
Sell Location: Chr1:163889556-163908354 bp, + strand Genetic Position: Chr1, 71.37 cM
|
Alliance: |
Selltm2Alb page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:70682
|
Parent Cell Line: |
AB2.1 (ES Cell)
|
Strain of Origin: |
129S7/SvEvBrd-Hprt1b-m2
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutations: |
|
Insertion, Intragenic deletion
|
|
|
Mutation details: The Sell gene was disrupted by insertion of a puromycin resistance cassette in opposite orientation into the coding sequence via homologous recombination. The construct was injected into ES cells already carrying mutations in Sele and Selp. Clones where the targeting vector inserted in cis to the Sele and Selp mutations were used to produce triple selectin-null mutant mice.
(J:70682)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Sell Mutation: |
42 strains or lines available
|
|
Original: |
J:70682 Collins RG, et al., Dermal and pulmonary inflammatory disease in E-selectin and P-selectin double-null mice is reduced in triple-selectin-null mice. Blood. 2001 Aug 1;98(3):727-35 |
All: |
4 reference(s) |
|